XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Income (Loss) - USD ($)
 3 Months Ended 6 Months Ended
Jul. 29, 2023
Jul. 30, 2022
Jul. 29, 2023
Jul. 30, 2022
Income Statement [Abstract]        
Revenue $ 35,524,000 $ 32,259,000 $ 70,943,000 $ 63,269,000
Cost of Revenue 25,814,000 20,877,000 48,847,000 41,158,000
Gross Profit 9,710,000 11,382,000 22,096,000 22,111,000
Operating Expenses:        
Selling and Marketing 6,697,000 5,981,000 12,707,000 11,863,000
Research and Development 1,557,000 1,595,000 3,345,000 3,118,000
General and Administrative 2,654,000 2,571,000 5,780,000 5,131,000
Operating Expenses 10,908,000 10,147,000 21,832,000 20,112,000
Operating Income (Loss) (1,198,000) 1,235,000 264,000 1,999,000
Other Income (Expense), net:        
Interest Expense (674,000) (210,000) (1,289,000) (385,000)
Loss on Foreign Currency Transactions (197,000) (242,000) (11,000) (377,000)
Other, net 62,000 21,000 56,000 52,000
Other Income (Expense), net (809,000) (431,000) (1,244,000) (710,000)
Income (Loss) Before Income Taxes (2,007,000) 804,000 (980,000) 1,289,000
Income Tax Provision (Benefit) (390,000) 220,000 (211,000) 280,000
Net Income (Loss) $ (1,617,000) $ 584,000 $ (769,000) $ 1,009,000
Net Income (Loss) per Common Share-Basic $ (0.22) $ 0.08 $ (0.1) $ 0.14
Net Income (Loss) per Common Share-Diluted $ (0.22) $ 0.08 $ (0.1) $ 0.14
Weighted Average Number of Common Shares Outstanding—Basic 7,420,135 7,309,716 7,396,200 7,286,735
Weighted Average Number of Common Shares Outstanding—Diluted 7,420,135 7,347,946 7,396,200 7,354,707